Fulminant Myocarditis: Epidemiology, Pathogenesis, Diagnosis, and Management

Ajay Nair Sharma, Jacob Randolph Stultz, Nikhil Bellamkonda, Ezra Abraham Amsterdam

Research output: Contribution to journalReview article

Abstract

Fulminant myocarditis (FM) is a rare, distinct form of myocarditis that has been difficult to classify. Since 1991, the definition of FM has evolved, and it is currently considered an acute illness with hemodynamic derangement and arrhythmias due to a severe inflammatory process requiring support of cardiac pump function and/or urgent management of serious arrhythmias. Diagnosis is aided through use of biomarkers and cardiac imaging, but endocardial biopsy remains the gold standard. Recent evidence has revealed that patients with FM are significantly more likely to die or require heart transplantation than those with the nonfulminant form, refuting previous studies proposing a paradoxically low mortality in patients with FM. Acute hemodynamic derangement is managed by intensive contemporary pharmacologic and interventional approaches, whereas the role of immunosuppressive therapy has not been clarified. Early recognition and aggressive management are essential for favorable outcomes. In conclusion, FM is an inflammatory process requiring intensive support, and it causes a higher morbidity and mortality than acute nonfulminant myocarditis.

Original languageEnglish (US)
JournalAmerican Journal of Cardiology
DOIs
StateAccepted/In press - Jan 1 2019

Fingerprint

Myocarditis
Epidemiology
Cardiac Arrhythmias
Hemodynamics
Mortality
Heart Transplantation
Immunosuppressive Agents
Biomarkers
Morbidity
Biopsy

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Fulminant Myocarditis : Epidemiology, Pathogenesis, Diagnosis, and Management. / Sharma, Ajay Nair; Stultz, Jacob Randolph; Bellamkonda, Nikhil; Amsterdam, Ezra Abraham.

In: American Journal of Cardiology, 01.01.2019.

Research output: Contribution to journalReview article

@article{121e66a64e9041f5b67065a3614198d8,
title = "Fulminant Myocarditis: Epidemiology, Pathogenesis, Diagnosis, and Management",
abstract = "Fulminant myocarditis (FM) is a rare, distinct form of myocarditis that has been difficult to classify. Since 1991, the definition of FM has evolved, and it is currently considered an acute illness with hemodynamic derangement and arrhythmias due to a severe inflammatory process requiring support of cardiac pump function and/or urgent management of serious arrhythmias. Diagnosis is aided through use of biomarkers and cardiac imaging, but endocardial biopsy remains the gold standard. Recent evidence has revealed that patients with FM are significantly more likely to die or require heart transplantation than those with the nonfulminant form, refuting previous studies proposing a paradoxically low mortality in patients with FM. Acute hemodynamic derangement is managed by intensive contemporary pharmacologic and interventional approaches, whereas the role of immunosuppressive therapy has not been clarified. Early recognition and aggressive management are essential for favorable outcomes. In conclusion, FM is an inflammatory process requiring intensive support, and it causes a higher morbidity and mortality than acute nonfulminant myocarditis.",
author = "Sharma, {Ajay Nair} and Stultz, {Jacob Randolph} and Nikhil Bellamkonda and Amsterdam, {Ezra Abraham}",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.amjcard.2019.09.017",
language = "English (US)",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Fulminant Myocarditis

T2 - Epidemiology, Pathogenesis, Diagnosis, and Management

AU - Sharma, Ajay Nair

AU - Stultz, Jacob Randolph

AU - Bellamkonda, Nikhil

AU - Amsterdam, Ezra Abraham

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Fulminant myocarditis (FM) is a rare, distinct form of myocarditis that has been difficult to classify. Since 1991, the definition of FM has evolved, and it is currently considered an acute illness with hemodynamic derangement and arrhythmias due to a severe inflammatory process requiring support of cardiac pump function and/or urgent management of serious arrhythmias. Diagnosis is aided through use of biomarkers and cardiac imaging, but endocardial biopsy remains the gold standard. Recent evidence has revealed that patients with FM are significantly more likely to die or require heart transplantation than those with the nonfulminant form, refuting previous studies proposing a paradoxically low mortality in patients with FM. Acute hemodynamic derangement is managed by intensive contemporary pharmacologic and interventional approaches, whereas the role of immunosuppressive therapy has not been clarified. Early recognition and aggressive management are essential for favorable outcomes. In conclusion, FM is an inflammatory process requiring intensive support, and it causes a higher morbidity and mortality than acute nonfulminant myocarditis.

AB - Fulminant myocarditis (FM) is a rare, distinct form of myocarditis that has been difficult to classify. Since 1991, the definition of FM has evolved, and it is currently considered an acute illness with hemodynamic derangement and arrhythmias due to a severe inflammatory process requiring support of cardiac pump function and/or urgent management of serious arrhythmias. Diagnosis is aided through use of biomarkers and cardiac imaging, but endocardial biopsy remains the gold standard. Recent evidence has revealed that patients with FM are significantly more likely to die or require heart transplantation than those with the nonfulminant form, refuting previous studies proposing a paradoxically low mortality in patients with FM. Acute hemodynamic derangement is managed by intensive contemporary pharmacologic and interventional approaches, whereas the role of immunosuppressive therapy has not been clarified. Early recognition and aggressive management are essential for favorable outcomes. In conclusion, FM is an inflammatory process requiring intensive support, and it causes a higher morbidity and mortality than acute nonfulminant myocarditis.

UR - http://www.scopus.com/inward/record.url?scp=85074426478&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85074426478&partnerID=8YFLogxK

U2 - 10.1016/j.amjcard.2019.09.017

DO - 10.1016/j.amjcard.2019.09.017

M3 - Review article

C2 - 31679645

AN - SCOPUS:85074426478

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

ER -